See more : Copper Fox Metals Inc. (CUU.V) Income Statement Analysis – Financial Results
Complete financial analysis of Itamar Medical Ltd. (ITMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Itamar Medical Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Bæredygtige Klimaaktier Akk. Kl (BAIBDA.CO) Income Statement Analysis – Financial Results
- Novint Technologies, Inc. (NVNT) Income Statement Analysis – Financial Results
- Medifast, Inc. (0K05.L) Income Statement Analysis – Financial Results
- PT Indomobil Multi Jasa Tbk (IMJS.JK) Income Statement Analysis – Financial Results
- CLP Holdings Limited (CLPHF) Income Statement Analysis – Financial Results
Itamar Medical Ltd. (ITMR)
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.03M | 31.26M | 24.19M | 20.70M | 18.44M | 16.81M | 16.39M | 13.34M | 13.43M |
| Cost of Revenue | 12.32M | 6.98M | 5.73M | 5.00M | 4.98M | 4.40M | 4.80M | 4.26M | 3.80M |
| Gross Profit | 28.71M | 24.27M | 18.46M | 15.70M | 13.46M | 12.41M | 11.59M | 9.08M | 9.62M |
| Gross Profit Ratio | 69.97% | 77.66% | 76.33% | 75.84% | 73.00% | 73.81% | 70.72% | 68.07% | 71.68% |
| Research & Development | 6.00M | 4.52M | 3.64M | 4.13M | 3.23M | 2.83M | 2.02M | 1.89M | 1.69M |
| General & Administrative | 8.50M | 6.35M | 5.25M | 5.28M | 5.36M | 4.30M | 4.63M | 4.88M | 2.55M |
| Selling & Marketing | 24.55M | 18.29M | 12.70M | 12.14M | 14.04M | 10.68M | 8.44M | 7.40M | 5.69M |
| SG&A | 33.05M | 24.65M | 17.95M | 17.42M | 19.40M | 14.98M | 13.07M | 12.28M | 8.23M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 849.00K | 52.00K | 113.00K | 117.00K | 217.00K |
| Operating Expenses | 39.06M | 29.17M | 21.58M | 21.55M | 23.47M | 17.87M | 15.20M | 14.29M | 10.14M |
| Cost & Expenses | 51.38M | 36.15M | 27.31M | 26.55M | 28.45M | 22.27M | 20.00M | 18.54M | 13.94M |
| Interest Income | 713.00K | 454.00K | 93.00K | 1.39M | 547.00K | 176.00K | -571.00K | 714.00K | 121.00K |
| Interest Expense | 562.00K | 284.00K | 794.00K | 4.43M | 4.61M | 4.19M | 2.51M | 4.83M | 2.12M |
| Depreciation & Amortization | 1.82M | 1.29M | 481.00K | 509.00K | 434.00K | 367.00K | 324.00K | 400.00K | 330.00K |
| EBITDA | -8.43M | -3.66M | -330.00K | -280.00K | -9.23M | 2.44M | -313.00K | -7.73M | 2.76M |
| EBITDA Ratio | -20.55% | -11.71% | -1.36% | -1.35% | -50.04% | 14.53% | -1.91% | -57.95% | 20.57% |
| Operating Income | -10.34M | -4.89M | -3.12M | -5.85M | -10.01M | -5.46M | -3.61M | -5.21M | -515.00K |
| Operating Income Ratio | -25.21% | -15.66% | -12.90% | -28.25% | -54.30% | -32.48% | -22.02% | -39.04% | -3.84% |
| Total Other Income/Expenses | -468.00K | -337.00K | 1.52M | 632.00K | -4.26M | 3.35M | 458.00K | -7.76M | 831.00K |
| Income Before Tax | -10.81M | -5.23M | -1.61M | -5.22M | -14.27M | -2.11M | -3.15M | -12.96M | 316.00K |
| Income Before Tax Ratio | -26.35% | -16.73% | -6.64% | -25.20% | -77.40% | -12.57% | -19.23% | -97.20% | 2.35% |
| Income Tax Expense | 127.00K | 37.00K | 124.00K | 85.00K | 131.00K | 135.00K | 124.00K | -44.00K | -201.00K |
| Net Income | -10.94M | -5.27M | -1.73M | -5.30M | -14.40M | -2.25M | -3.28M | -12.92M | 517.00K |
| Net Income Ratio | -26.66% | -16.85% | -7.15% | -25.61% | -78.11% | -13.37% | -19.99% | -96.87% | 3.85% |
| EPS | -0.79 | -0.46 | -0.17 | -0.60 | -1.65 | -0.35 | -0.56 | -2.82 | 0.03 |
| EPS Diluted | -0.79 | -0.46 | -0.17 | -0.52 | -1.65 | -0.29 | -0.46 | -2.82 | 0.03 |
| Weighted Avg Shares Out | 13.85M | 11.54M | 10.13M | 8.80M | 8.75M | 6.39M | 5.83M | 4.58M | 16.42M |
| Weighted Avg Shares Out (Dil) | 13.85M | 11.54M | 10.13M | 10.13M | 8.75M | 7.73M | 7.15M | 4.58M | 16.42M |
Itamar Medical: Q1 Earnings Insights
Shares of Itamar Medical (NASDAQ:ITMR) remained unaffected after the company reported Q1 results. Quarterly Results Earnings per share were down 81.82% over the past year to ($0.20), which missed the estimate of ($0.16).
Itamar Medical Reports First Quarter 2021 Results
– First Quarter 2021 Revenues Increase 43% to $12.0 Million –
Analysts Estimate Itamar Medical Ltd. Sponsored ADR (ITMR) to Report a Decline in Earnings: What to Look Out for
Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
Itamar Medical's WatchPAT® Technology Featured in Ladenburg Thalmann Healthcare Symposia Call Series
CAESAREA, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced its...
Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021
CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that...
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q4 2020 Results - Earnings Call Transcript
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q4 2020 Results - Earnings Call Transcript
Itamar Medical Ltd. Sponsored ADR (ITMR) Reports Q4 Loss, Tops Revenue Estimates
Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of -7.14% and 0.57%, respectively, for the quarter ended December 2020.
Itamar Medical Reports Record Fourth Quarter and Full Year 2020 Revenues
- Record Fourth Quarter 2020 Revenues Increase 31% to $ 12.8 Million -
Itamar Medical to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Tuesday, March 2, 2021
CAESAREA, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that...
Itamar Medical to Participate in Upcoming Investor Conferences
CAESAREA, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced...
Source: https://incomestatements.info
Category: Stock Reports